SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-245614
Filing Date
2023-09-28
Accepted
2023-09-28 16:05:53
Documents
15
Period of Report
2023-09-25
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d469125d8k.htm   iXBRL 8-K 27375
2 EX-99.1 d469125dex991.htm EX-99.1 11904
6 GRAPHIC g469125g0928050545995.jpg GRAPHIC 2269
7 GRAPHIC g469125g0928050546218.jpg GRAPHIC 3115
  Complete submission text file 0001193125-23-245614.txt   169492

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA teva-20230925.xsd EX-101.SCH 2845
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE teva-20230925_lab.xml EX-101.LAB 17168
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE teva-20230925_pre.xml EX-101.PRE 10785
9 EXTRACTED XBRL INSTANCE DOCUMENT d469125d8k_htm.xml XML 3367
Mailing Address TEVA PHARMACEUTICAL INDUSTRIES LIMITED 5 BAZEL ST PO B 3190 PETACH TIKVA L3 49131
Business Address 5 BAZEL ST P O B 3190 PETACH TIKVA L3 49131 9729267267
TEVA PHARMACEUTICAL INDUSTRIES LTD (Filer) CIK: 0000818686 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-16174 | Film No.: 231289524
SIC: 2834 Pharmaceutical Preparations